AWARENESS MONTHS

IDEAL - 15-20 MINUTE PRESENTATIONS | 40-60 MIN INTERVIEWS | 

Awareness Months by Condition and Prevalence

October Awareness Month (AM):

Chronic Pain – National Physical Therapy & Chiropractic Health Month |  U.S. Incidence: ≈50 million adults (20% of the population)

Depression – Depression SCREENING - 1ST WEEK IN OCTOBER | U.S. Incidence: ≈21 million adults (8.4% of the population)

Breast Cancer – Breast Cancer Awareness Month | U.S. Incidence: ≈297,790 new invasive cases annually (≈1 in 8 women)

Liver Cancer – Liver Cancer Awareness Month | U.S. Incidence: ≈41,210 new cases annually (≈0.012% of the population)

Domestic Violence Awareness Month | U.S. Incidence: ≈1 in 4 women and ≈1 in 9 men experience severe intimate partner violence.

Sudden Infant Death Syndrome (SIDS) Awareness Month | U.S. Incidence: ≈3,400 deaths annually

Pregnancy and Infant Loss Awareness Month | U.S. Incidence: ≈24,000 stillbirths annually

National Spina Bifida Awareness Month | U.S. Incidence: ≈166,000 people living with Spina Bifida

Eye Injury Prevention Month | U.S. Incidence: ≈2.4 million eye injuries annually

Healthy Lung Month | U.S. Incidence: ≈16 million people affected by lung disease, including COPD


November Awareness Month (AM):

Post-Traumatic Stress Disorder (PTSD) – Veterans Day / Military Family Appreciation Month | U.S. Incidence: ≈12 million adults annually (3.6% of the population)

Alzheimer’s Disease – Alzheimer’s Awareness Month | U.S. Incidence: ≈6.7 million people (2.0% of the population)

Epilepsy – Epilepsy Awareness Month | U.S. Incidence: ≈3.4 million people (1.03% of the population)

Crohn’s Disease – Crohn's and Colitis Awareness Month | U.S. Incidence: ≈780,000 people (0.24% of the population)

Diabetes / Diabetic Peripheral Neuropathy (DPN) – Diabetes Awareness Month | U.S. Incidence: ≈37.3 million people with diabetes (11.3% of the population)
DPN Prevalence: ≈50% of people with diabetes, affecting ≈18.65 million in the U.S.

Chronic Obstructive Pulmonary Disease (COPD) – COPD Awareness Month | U.S. Incidence: ≈16 million diagnosed cases (6.4% of the adult population)

Lung Cancer – Lung Cancer Awareness Month | U.S. Incidence: ≈230,000 new cases annually

Stomach Cancer – Stomach Cancer Awareness Month | U.S. Incidence: ≈26,500 new cases annually

National Hospice and Palliative Care Month | U.S. Incidence: ≈1.61 million patients received hospice care in 2022

Bladder Health Month | U.S. Incidence: ≈83,000 new cases of bladder cancer annually

National Family Caregivers Month | U.S. Incidence: ≈53 million caregivers in the U.S.

National Healthy Skin Month | U.S. Incidence: ≈9,500 people diagnosed with skin cancer daily

National Family Health History Day (November 23, Thanksgiving Day)


December Awareness Month (AM):
December highlights HIV/AIDS AM, World AIDS Day, National Handwashing Awareness Week.

January Awareness Month (AM):
January focuses on Cervical Cancer AM, National Birth Defects Prevention, National Blood Donor Month, Thyroid Awareness Month, Glaucoma AM, Mental Wellness Month.

February Awareness Month (AM):
February observes National Cancer Prevention Month, American Heart Month, National Children’s Dental Health Month, Age-Related Macular Degeneration AM, and Teen Dating Violence Awareness Month.

March Awareness Month (AM):
March emphasizes Multiple Sclerosis AM (≈1 million affected in the U.S.), Traumatic Brain Injury AM, National Sleep Awareness, Colorectal Cancer AM (≈150,000 new cases/year in the U.S.), National Endometriosis AM, National Kidney Month, and National Nutrition Month.

April Awareness Month (AM):
April is dedicated to Stress AM, Parkinson’s AM, National Autism AM, National Minority Health Month, Testicular Cancer AM, National Donate Life Month, and Irritable Bowel Syndrome (IBS) AM.

May Awareness Month (AM):
May raises awareness for ALS AM, Mental Health AM (≈21% of U.S. adults with mental illness), Neuropathy Awareness Week, Melanoma/Skin Cancer Detection and Prevention Month, National Stroke Awareness Month, Lupus AM, National Asthma and Allergy AM, National Osteoporosis Month, Hepatitis Awareness Month, and National Women’s Health Week.

June Awareness Month (AM):
June includes Cancer Survivors Month, PTSD AM (≈12 million affected/year in the U.S.), Migraine and Headache AM, National Cancer Survivors Day, Men’s Health Month, Scoliosis AM, Cataract AM, and Aphasia AM.

July Awareness Month (AM):
July focuses on Minority Mental Health Month, Juvenile Arthritis AM, UV Safety Month, National Cord Blood AM, International Group B Strep Awareness Month.

August Awareness Month (AM):
August emphasizes National Immunization AM, Psoriasis AM (≈7.5 million U.S. cases), Children’s Eye Health and Safety Month, National Breastfeeding Month, and Gastroparesis AM.

These awareness months provide valuable opportunities for education, advocacy, and support, particularly for conditions related to pain and mental health, which affect millions worldwide.

September Awareness Month (AM):
September is a critical month for numerous health conditions, highlighting Pain Awareness (affecting millions globally), Prostate Cancer (1 in 8 men in the U.S.), National Sickle Cell AM (≈100,000 in the U.S.), National Recovery Month, , National Yoga AM, National Cholesterol Education Month, National Atrial Fibrillation AM (≈6 million U.S. cases), National Polycystic Ovary Syndrome AM (≈5-10% of women), Ovarian Cancer AM, Blood Cancer AM (leukemia, lymphoma, myeloma combined ≈1.5 million living with or in remission), Suicide Prevention Week (≈48,000 deaths/year in the U.S.), Childhood Cancer AM, and National Pain AM.


OCTOBER IS BREAST CANCER AWARENESS MONTH 

1. Chronic Pain


2. Depression

For Depression screening, common tools are PHQ-9 (Patient Health Questionnaire-9),  Beck Depression Inventory (BDI-II),  Hamilton Depression Rating Scale (HAM-D).  FYI - I feel that the tools to assess Cannabis Use Disorder (CUD) are fairly inaccurate due to poor consideration of medical goals in the scoring. 


3. Post-Traumatic Stress Disorder (PTSD)


4. Alzheimer’s Disease


5. Epilepsy


6. Crohn’s Disease


7. Breast Cancer


8. Liver Cancer


9. Diabetes / Diabetic Peripheral Neuropathy (DPN)


10. Chronic Obstructive Pulmonary Disease (COPD)

Health, Mental Health, Safety, Senior Issues, Pain, Minority Health, and Cultural Awareness Months

Key Awareness Weeks Related to Minority Health, Safety, Senior Issues, and Pain

How cannabis helps ... 

January:
Glaucoma Awareness Month
Cannabis ↓ intraocular pressure by modulating endocannabinoid signaling in the ciliary epithelium, though effects are transient. It is most beneficial in acute cases but requires frequent dosing due to short action duration.

February:
American Heart Month
While cannabis modulates vascular tone via CB1 receptor activation and induces vasodilation, chronic use in high-risk cardiac patients may need caution due to the risk of increased heart rate and cardiac arrhythmias.

Black History Month
Cannabis use can help reduce chronic pain and PTSD symptoms, conditions disproportionately affecting African Americans. For example, it aids in trauma recovery by reducing amygdala hyperactivation via CB1 receptors.

March:
Colorectal Cancer Awareness Month
Cannabinoids ↓ tumor cell proliferation and induce apoptosis via CB1/CB2 receptor activation in colorectal cancer, offering potential adjunctive cancer therapy with anti-inflammatory benefits.

April:
Stress Awareness Month
THC and CBD modulate the hypothalamic-pituitary-adrenal (HPA) axis, ↓ cortisol secretion, and alleviate stress and anxiety symptoms. Cannabis may also help with stress-induced neuroinflammation, improving coping mechanisms.

National Autism Awareness Month
CBD’s modulation of GABAergic transmission and glutamatergic signaling shows promise in reducing seizures and behavioral issues in children with autism, with studies showing improvement in hyperactivity and communication.

National Minority Health Month
Cannabis can help reduce health disparities by offering an alternative treatment for pain, PTSD, and chronic conditions, which disproportionately affect minority populations, especially where traditional medications fail or are less accessible.

May:
Mental Health Awareness Month
Cannabinoids interact with serotonergic and GABAergic systems to stabilize mood. However, while they may help alleviate depression and anxiety, chronic high doses of THC may ↑ risks of psychosis or exacerbate symptoms in vulnerable populations.

Arthritis Awareness Month (pain and senior health)
Cannabinoids ↓ inflammation and joint pain by acting on CB2 receptors located on immune cells. Clinical studies show up to a 30% improvement in pain scores for arthritis patients using cannabis-based medications.

June:
Alzheimer's & Brain Awareness Month
Cannabis may protect against β-amyloid-induced neurotoxicity by modulating CB2 receptors on microglia, ↓ neuroinflammation and oxidative stress, thus potentially delaying the progression of Alzheimer’s disease.

PTSD Awareness Month
Cannabinoids, particularly THC, act on CB1 receptors to modulate fear extinction and reduce symptoms of hyperarousal and flashbacks in PTSD patients, with clinical studies showing 75% symptom relief in veterans using medical cannabis.

Migraine and Headache Awareness Month (pain)
Cannabinoids inhibit calcitonin gene-related peptide (CGRP) and modulate serotonin receptors, which are involved in the pathophysiology of migraines, leading to reductions in both frequency and intensity of migraine attacks.

July:
Minority Mental Health Awareness Month
Cannabis offers relief for mental health challenges in minority populations by modulating the endocannabinoid system, which plays a critical role in mood regulation, although it requires cautious use due to a higher risk of cannabis use disorder in certain groups.

September:
Pain Awareness Month
Cannabinoids activate CB1/CB2 receptors in the central and peripheral nervous systems, ↓ pain signaling and inflammation, offering significant relief for chronic pain patients, including those with neuropathic, fibromyalgia, and inflammatory pain.

Healthy Aging Month (senior issues)
Cannabis helps manage chronic pain, improve sleep quality, and ↓ inflammation in seniors, particularly those suffering from arthritis or age-related degenerative diseases, by modulating CB2 receptors on immune cells and reducing proinflammatory cytokines.

October:
National Depression and Mental Health Screening Month
Cannabis may provide antidepressant effects by enhancing anandamide levels via inhibition of FAAH, improving mood and emotional regulation in patients with depressive disorders, although dosage is critical to avoid exacerbation.

November:
Movember (Men’s Health Awareness, including mental health and suicide prevention)
Cannabis reduces depressive symptoms and suicide ideation by modulating the endocannabinoid and serotonergic pathways, though care must be taken as chronic THC use could ↑ the risk of suicidal behavior in predisposed individuals.

Lung Cancer Awareness Month
While smoking cannabis may pose risks to lung health, cannabinoids exhibit anti-tumor properties, inducing apoptosis and inhibiting cancer cell proliferation via CB1/CB2 receptors and by downregulating proinflammatory pathways in non-smoked forms (e.g., oils, edibles).

Diabetes Awareness Month
Cannabinoids may help regulate insulin sensitivity and reduce inflammatory markers in type 2 diabetes by interacting with CB1 receptors on pancreatic β-cells, leading to improved glucose metabolism and potential reductions in HbA1c levels.

December:
Older Driver Safety Awareness Week (senior safety)
Cannabis can help seniors manage conditions like arthritis and neuropathy, improving mobility and quality of life, though dosing must be carefully monitored to avoid cognitive and motor impairments that could ↑ risk of accidents.

How cannabis helps plus Global | U.S. | Florida stats ... 

Breast Cancer Awareness Month (October)
Cannabinoids, particularly CBD, show potential in inhibiting the proliferation of breast cancer cells by inducing apoptosis and modulating HER2 and CB1/CB2 receptor pathways. Studies suggest that CBD can inhibit Id-1 gene expression, which is involved in metastasis. While cannabis may not be a primary treatment, it provides palliative benefits such as pain relief, nausea control, and improved sleep for patients undergoing chemotherapy.

Breast Cancer Statistics:


Glaucoma Awareness Month (January)
Cannabinoids lower intraocular pressure (IOP) by interacting with the CB1 receptors in the ciliary body, a key mechanism in reducing IOP in glaucoma patients. However, the effects are short-lived, requiring frequent dosing, which limits its practical use as a primary treatment for glaucoma.

Glaucoma Statistics:


American Heart Month (February)
Cannabinoids, particularly THC, act on CB1 receptors on vascular smooth muscle, causing vasodilation and a temporary reduction in blood pressure. However, chronic cannabis use may lead to increased heart rate and heightened risk of arrhythmias in some individuals, particularly those with underlying cardiovascular conditions.

Cardiovascular Disease Statistics:


Mental Health Awareness Month (May)
Cannabis offers potential benefits for treating anxiety and depression by interacting with CB1 receptors and the serotonergic system, resulting in mood stabilization. However, the biphasic effects of THC (low doses ↓ anxiety; high doses ↑ anxiety) warrant careful dosing. Cannabis-based therapies may be particularly beneficial in PTSD, with studies showing a 75% improvement in symptom severity in veterans using medical cannabis.

Mental Health Statistics:


Pain Awareness Month (September)
Cannabinoids act on CB1 receptors in the dorsal horn and peripheral nervous system to reduce nociceptive signaling, providing analgesic effects for chronic and neuropathic pain conditions. Studies show that patients with chronic pain who used cannabis experienced a 40–60% reduction in pain severity compared to placebo (Ware et al., 2010).

Pain Statistics:


Diabetes Awareness Month (November)
Cannabinoids, especially CBD, have been shown to modulate insulin sensitivity and reduce inflammatory markers associated with type 2 diabetes. By activating CB1 receptors on pancreatic β-cells, cannabinoids may improve glucose metabolism and insulin regulation, contributing to better long-term glycemic control.

Diabetes Statistics:


Lung Cancer Awareness Month (November)
Cannabinoids like THC and CBD exhibit anti-tumor properties in preclinical models, inducing apoptosis in lung cancer cell lines and inhibiting angiogenesis. In addition to their anti-cancer potential, cannabinoids are used to alleviate chemotherapy-induced nausea, pain, and cachexia.

Lung Cancer Statistics:


Cannabis holds promise as a therapeutic tool for a variety of conditions, particularly when considering its mechanisms of action involving CB1 and CB2 receptors, its role in inflammatory pathways, and its potential for neuroprotection. However, individual risk profiles, including the possibility of cannabis use disorder, emphasize the need for cautious, personalized medical use.

Global Population: ≈8.05B | U.S. Population: ≈335M |China: ≈1.42B | India: ≈1.42B | United States: ≈335M | Indonesia: ≈277M | Pakistan: ≈240M | Nigeria: ≈225M | Brazil: ≈217M | Bangladesh: ≈171M | Russia: ≈145M | Mexico: ≈130M | Japan: ≈124M | Ethiopia: ≈127M | Philippines: ≈118M | Egypt: ≈112M | Vietnam: ≈100M | DR Congo: ≈103M | Turkey: ≈87M | Iran: ≈89M | Germany: ≈83M | Thailand: ≈71M | UK: ≈69M | France: ≈66M | Italy: ≈58M | South Africa: ≈60M | Tanzania: ≈67M | Myanmar: ≈56M | South Korea: ≈51M | Colombia: ≈53M | Kenya: ≈54M | Spain: ≈47M (JAMAICA APPROX 3M)

California: ≈39.5M | Texas: ≈30.2M | Florida: ≈22.6M | New York: ≈19.9M | Pennsylvania: ≈12.8M | Illinois: ≈12.5M | Ohio: ≈11.7M | Georgia: ≈10.9M | North Carolina: ≈10.8M | Michigan: ≈10.1M | New Jersey: ≈9.4M | Virginia: ≈8.8M | Washington: ≈7.9M | Arizona: ≈7.6M | Massachusetts: ≈7M | Tennessee: ≈7M | Indiana: ≈6.8M | Missouri: ≈6.2M | Maryland: ≈6.2M | Wisconsin: ≈5.9M | Colorado: ≈5.9M | Minnesota: ≈5.8M | South Carolina: ≈5.4M | Alabama: ≈5.1M | Louisiana: ≈4.6M | Kentucky: ≈4.5M | Oregon: ≈4.3M | Oklahoma: ≈4M | Connecticut: ≈3.6M | Utah: ≈3.4M | Iowa: ≈3.2M | Nevada: ≈3.2M | Arkansas: ≈3M | Mississippi: ≈2.9M | Kansas: ≈2.9M | New Mexico: ≈2.1M | Nebraska: ≈1.9M | West Virginia: ≈1.8M | Idaho: ≈1.9M | Hawaii: ≈1.4M | Maine: ≈1.4M | New Hampshire: ≈1.4M | Montana: ≈1.1M | Rhode Island: ≈1.1M | Delaware: ≈1M | South Dakota: ≈900K | North Dakota: ≈780K | Alaska: ≈730K | Vermont: ≈640K | Wyoming: ≈580K 

October:

Breast Cancer Awareness Month | Depression Awareness Month | Domestic Violence Awareness Month | Liver Cancer Awareness Month | National Chiropractic Health Month | National Physical Therapy Month | Healthy Lung Month | Sudden Infant Death Syndrome (SIDS) Awareness Month | Pregnancy and Infant Loss Awareness Month | National Spina Bifida Awareness Month | Eye Injury Prevention Month | National Bullying Prevention Month | National ADHD Awareness Month

Weeks/Days in October:

Mental Illness Awareness Week – October 1-7 | World Mental Health Day – October 10 | National Depression Screening Day – October 5 | Bone and Joint Health Action Week – October 12-20 | International Day of Older Persons – October 1 | National Coming Out Day – October 11 | Veterans Day – October 27 (some regions)

November:

American Diabetes Month | Epilepsy Awareness Month | Crohn’s and Colitis Awareness Month | National Alzheimer’s Disease Awareness Month | Lung Cancer Awareness Month | Stomach Cancer Awareness Month | National Hospice and Palliative Care Month | Bladder Health Month | National Family Caregivers Month | National Healthy Skin Month | Military Family Month | Veterans Awareness Month | National Adoption Awareness Month

Weeks/Days in November:

National Alzheimer’s Disease Awareness Week – November 1-7 | National Family Health History Day – November 23 (Thanksgiving) | Veterans Day – November 11 | Great American Smokeout – Third Thursday of November

December:

National Influenza Vaccination Week – December 1-7 | International Day of Persons with Disabilities – December 3 | Safe Toys and Gifts Month | National Handwashing Awareness Week – December 1-7 | Universal Human Rights Month

FLORIDA / GA QCs

Florida Qualified Conditions:

Cancer | Epilepsy | Glaucoma | HIV/AIDS | Post-Traumatic Stress Disorder (PTSD) | Amyotrophic Lateral Sclerosis (ALS) | Crohn’s Disease | Parkinson’s Disease | Multiple Sclerosis (MS) | Chronic Nonmalignant Pain | Medical conditions of the same kind or class as or comparable to those above | Terminal Illness | Chronic pain related to a qualifying condition | Seizures | Severe and persistent muscle spasms

Neurologic Conditions:

Epilepsy | Post-Traumatic Stress Disorder (PTSD) | Amyotrophic Lateral Sclerosis (ALS) | Parkinson’s Disease | Multiple Sclerosis (MS) | Seizures | Severe and persistent muscle spasms

Pain Conditions:

Cancer | Chronic Nonmalignant Pain | Chronic pain related to a qualifying condition

Other Categories:

Glaucoma | HIV/AIDS | Crohn’s Disease | Medical conditions of the same kind or class as or comparable to those above | Terminal Illness


Georgia Qualified Conditions (Low-THC Oil):

Cancer (end-stage or related wasting illness or severe pain) | Amyotrophic Lateral Sclerosis (ALS) | Seizure disorders (related to epilepsy or trauma-related head injuries) | Multiple Sclerosis (severe or end-stage) | Crohn’s Disease | Mitochondrial Disease | Parkinson’s Disease (severe or end-stage) | Sickle Cell Disease (severe or end-stage) | Tourette’s Syndrome (severe) | Autism Spectrum Disorder (under 18 or severe in adults) | Epidermolysis Bullosa | Alzheimer’s Disease (severe or end-stage) | AIDS/HIV | Peripheral Neuropathy (severe or end-stage) | PTSD (post-traumatic stress) | Intractable Pain | Hospice Care

Neurologic Conditions:

Amyotrophic Lateral Sclerosis (ALS) | Seizure Disorders (related to epilepsy or trauma-related head injuries) | Multiple Sclerosis (severe or end-stage) | Parkinson’s Disease (severe or end-stage) | Tourette’s Syndrome (severe) | Autism Spectrum Disorder (under 18 or severe in adults) | Alzheimer’s Disease (severe or end-stage) | Mitochondrial Disease

Pain Conditions:

Cancer (end-stage or related wasting illness or severe pain) | Crohn’s Disease | Sickle Cell Disease (severe or end-stage) | Peripheral Neuropathy (severe or end-stage) | Intractable Pain

Other Categories:

AIDS/HIV | Epidermolysis Bullosa | PTSD (post-traumatic stress) | Hospice Care (patients in hospice care, regardless of diagnosis)


Pain Conditions:

Chronic Nonmalignant Pain: ≈50M (U.S.) | ≈4M (FL) | Chronic Pain Related to a Qualifying Condition: Related to chronic pain stats (U.S.) | Related to chronic pain stats (FL)

Cancer: ≈1.9M new cases yearly (U.S.) | ≈154K new cases yearly (FL)  

Psychiatric (Psych) Conditions:

Post-Traumatic Stress Disorder (PTSD): ≈12M adults annually (U.S.) | ≈900K (FL)

Neurologic Conditions:

Epilepsy: ≈3.4M (U.S.) | ≈400K (FL) | Amyotrophic Lateral Sclerosis (ALS): ≈30K (U.S.) | ≈1.5K (FL) | Parkinson’s Disease: ≈1M (U.S.) | ≈64K (FL) | Multiple Sclerosis (MS): ≈1M (U.S.) | ≈25K (FL) | Seizures: Part of epilepsy population (U.S.) | Part of epilepsy population (FL) | Severe and Persistent Muscle Spasms: Common in MS/ALS patients (U.S.) | Common in MS/ALS patients (FL)

Other Categories:

Glaucoma: ≈3M (U.S.) | ≈200K (FL) | HIV/AIDS: ≈1.2M (U.S.) | ≈120K (FL) | Crohn’s Disease: ≈780K (U.S.) | ≈50K (FL) | Medical Conditions of the Same Kind or Class: No specific stats | Terminal Illness: Dependent on disease (U.S.) | Dependent on disease (FL)

Pain Conditions:

Cancer (end-stage or related wasting illness or severe pain): ≈1.9M new cases yearly (U.S.) | ≈56K new cases yearly (GA) | Crohn’s Disease: ≈780K (U.S.) | ≈28K (GA) | Sickle Cell Disease (severe or end-stage): ≈100K (U.S.) | ≈7.5K (GA) | Peripheral Neuropathy (severe or end-stage): ≈20M (U.S.) | ≈600K (GA) | Intractable Pain: ≈20% of U.S. adults report chronic pain | ≈1.7M (GA)

Neurologic Conditions:

Amyotrophic Lateral Sclerosis (ALS): ≈30K (U.S.) | ≈1.5K (GA) | Seizure Disorders (related to epilepsy or trauma-related head injuries): ≈3.4M (U.S.) | ≈110K (GA) | Multiple Sclerosis (severe or end-stage): ≈1M (U.S.) | ≈25K (GA) | Parkinson’s Disease (severe or end-stage): ≈1M (U.S.) | ≈23K (GA) | Tourette’s Syndrome (severe): ≈200K with severe symptoms (U.S.) | Unknown (GA) | Autism Spectrum Disorder (severe): ≈5.4M (U.S.) | ≈150K (GA) | Alzheimer’s Disease (severe or end-stage): ≈6.7M (U.S.) | ≈150K (GA) | Mitochondrial Disease: ≈20K affected (U.S.) | Unknown (GA)

Psychiatric (Psych) Conditions:

PTSD (post-traumatic stress): ≈12M adults annually (U.S.) | ≈450K (GA)

Rare Conditions:

Epidermolysis Bullosa: ≈30K (U.S.) | Unknown (GA) | Mitochondrial Disease: ≈20K (U.S.) | Unknown (GA)

Other Categories:

AIDS/HIV: ≈1.2M (U.S.) | ≈58K (GA) | Hospice Care (patients in hospice care, regardless of diagnosis): ≈1.6M (U.S.) | ≈50K (GA)



Disclaimer: Information provided is for reference only and does not imply affiliation or endorsement with the mentioned individuals, companies, products, services, treatments, and websites. For informational purposes only - contact your medical provider for health and medical advice.  Content accuracy, completeness, and timeliness are not guaranteed. Inclusion of information and websites does not constitute endorsement. Users should exercise caution when accessing external content. See your medical, legal, finance, tax, spiritual and other professionals for discussion, guidance, planning, recommendations and greater understanding of the risks, benefits, options and ability to apply any information to your situation.